Skip to main content

Table 3 Incidence of cardio-cerebrovascular events (/1000 persons/year) (95%CI)

From: Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes

Patients

Group

Total cardio-cerebrovascular events

Myocardial infarction

Cerebral infarction

Cerebral hemorrhage

Total

Diabetes

3.5 (3.37–3.78)

2.3 (2.17–2.88)

1.5 (1.37–1.78)

0.8 (0.66–0.98)

Diabetes combined with hyperlipidemia

6.4 (6.09–7.04)a

4.4 (4.11–4.91)a

3.4 (3.24–3.81)a

1.6 (1.42–1.81)a

< 65 years

Diabetes

3.6 (3.57–4.18)

2.5 (2.37–2.78)

1.8 (1.68–1.96)

0.7 (0.6–0.78)

Diabetes combined with hyperlipidemia

5.2 (5.01–5.5)a

4.1 (3.8–4.21)a

1.7 (1.64–1.81)

0.6 (0.45–0.81)

≥ 65 years

Diabetes

2.6 (2.47–2.88)

1.8 (1.67–1.94)

1.2 (1.08–1.36)

0.6 (0.57–0.78)

Diabetes combined with hyperlipidemia

2.8 (2.71–2.91)

1.7 (1.66–2.01)

1.3 (1.24–1.41)

0.5 (0.45–0.65)

Females

Diabetes

2.5 (2.37–2.75)

1.9 (1.78–2.04)

1.1 (1.01–1.26)

0.5 (0.38–0.61)

Diabetes combined with hyperlipidemia

4.1 (4.01–4.2)a

3.1 (2.8–3.21)a

1.2 (1.04–1.31)

0.6 (0.55–0.71)

Males

Diabetes

3.2 (3.13–3.4)

2.5 (2.31–2.65)

1.7 (1.57–1.88)

0.9 (0.76–1.08)

Diabetes combined with hyperlipidemia

6.1 (5.89–6.44)a

4.8 (4.61–5.2)a

2.8 (2.74–3.01)a

1.4 (1.22–1.61)a

  1. CI confidence interval
  2. Note: aP < 0.05, which is compared with the same patients in diabetes group